Progestational Agents to Prevent Preterm Birth: A Meta-Analysis of Randomized Controlled Trials

@article{SnchezRamos2005ProgestationalAT,
  title={Progestational Agents to Prevent Preterm Birth: A Meta-Analysis of Randomized Controlled Trials},
  author={Luis S{\'a}nchez-Ramos and Andrew M. Kaunitz and Isaac Delke},
  journal={Obstetrics \& Gynecology},
  year={2005},
  volume={105},
  pages={273-279}
}
OBJECTIVE: To perform an updated systematic review with meta-analysis to further elucidate the efficacy of progestational agents for the prevention of preterm births in patients at elevated risk. DATA SOURCES: Computerized databases, references in published studies, and textbook chapters in all languages were used to identify randomized controlled trials (RCTs) evaluating the use of progestational agents for the prevention of preterm births in women at elevated risk. METHODS OF STUDY SELECTION… Expand
Progestogens as Maintenance Treatment in Arrested Preterm Labor: A Systematic Review and Meta-analysis
TLDR
There is insufficient high-quality data to inform clinicians and patients about the use of progestogens as maintenance treatment after arrested preterm labor to reduce the incidence of preterm birth or pregnancy prolongation. Expand
Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials.
TLDR
Progestational agents, initiated in the second trimester of pregnancy, may reduce the risk of delivery less than 37 weeks' gestation, among women at increased risk of spontaneous preterm birth, but the effect on neonatal outcome is uncertain. Expand
Progesterone for the prevention of preterm birth: a critical evaluation of evidence.
TLDR
A systematic review of the literature identified nine randomised trials that evaluated the effects of progestational agents in the prevention of preterm delivery and found that the benefit was consistent across a range of risks. Expand
Progesterone Therapy for the Prevention of Preterm Labor in Women with Single Risk-factor: A Systematic Review and Meta-analysis
TLDR
Progesterone therapy is an effective intervention for the prevention of preterm labor in women with single risk factor and its effect on gestational age at delivery is significant statically. Expand
Progesterone for preterm birth prevention: an evolving intervention.
TLDR
Individual trials and metaanalyses support that synthetic intramuscular 17-alpha-hydroxyprogesterone effectively reduces the incidence of recurrent PTB in women with a history of spontaneous PTB and suggest that in some women, progesterone reduces the risk of PTB. Expand
Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
  • V. Berghella
  • Medicine
  • American journal of obstetrics and gynecology
  • 2012
TLDR
Recommendations are made that in women with singleton gestations, no prior PTB, and short CL ≤ 20 mm at ≤ 24 weeks, vaginal progesterone, either 90-mg gel or 200-mg suppository, is associated with reduction in PTB and perinatal morbidity and mortality, and can be offered in these cases. Expand
Trial protocol OPPTIMUM– Does progesterone prophylaxis for the prevention of preterm labour improve outcome?
TLDR
The OPPTIMUM study is a double blind randomized placebo controlled trial to determine whether progesterone prophylaxis to prevent preterm birth has long term neonatal or infant benefit. Expand
Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies
TLDR
In women with a singleton pregnancy and previous preterm delivery, progesterone reduces the rates of pre term delivery before 32 weeks, perinatal death, as well as respiratory distress syndrome and necrotizing enterocolitis in the newborn. Expand
Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial
TLDR
Prophylactic vaginal progesterone reduced the rate of preterm labor and preterm delivery in high-risk pregnancies and there was no significant difference in neonatal death between placebo and progester one groups. Expand
The effectiveness of medical interventions aimed at preventing preterm birth: a literature review.
TLDR
Providing holistic, antenatal midwifery care for women living in socio-economic disadvantage and/or with an increased risk of preterm birth seems to be a promising strategy to address the negative effects of the social determinants of disease and thus to reduce the rate of pre term births at an individual and a population level. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
A meta-analysis of randomized control trials of progestational agents in pregnancy.
TLDR
The conclusion is that progestogens should not be used outside of randomized trials at present, and only women with demonstrated hormonal abnormalities who are carrying a live fetus as shown by ultrasonography should be included. Expand
Progestogen administration in pregnancy may prevent preterm delivery
  • M. Keirse
  • Medicine
  • British journal of obstetrics and gynaecology
  • 1990
TLDR
This analysis provides no support for the view that 17ahydroxyprogesterone caproate protects against miscarriage, but suggests that it does reduce the occurrence of preterm birth. Expand
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.
BACKGROUND Women who have had a spontaneous preterm delivery are at greatly increased risk for preterm delivery in subsequent pregnancies. The results of several small trials have suggested that 17Expand
Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.
TLDR
Prophylactic vaginal progesterone reduced the frequency of uterine contractions and the rate of preterm delivery in women at high risk for prematurity in a high-risk population. Expand
Beta‐mimetics in preterm labour: an overview of the randomized controlled trials
TLDR
An unequivocal effect of beta‐mimetic tocolytic administration in delaying delivery is demonstrated, reflected in a reduction in the frequency of preterm birth and low birthweight, but no beneficial effect of this treatment on perinatal mortality or severe neonatal respiratory disorders could be detected. Expand
Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta‐analysis of controlled trials
  • S. Daya
  • Medicine
  • British journal of obstetrics and gynaecology
  • 1989
TLDR
There is evidence to support the suggestion that progesterone given in early pregnancy is useful in women with recurrent miscarriage, according to the resulting odds ratio for pregnancies reaching at least 20 weeks gestation. Expand
Individualising use of aspirin to prevent pre‐eclampsia: a framework for clinical decision making
TLDR
The clinical usefulness of aspirin to prevent preeclampsia and perinatal death is explored using a decision-making framework based on individualising treatment among women at a defined risk level as identified by uterine artery Doppler test during ultrasound screening in the second trimester of pregnancy. Expand
Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate
Preterm delivery before 37 completed weeks gestation remains the major factor influencing infant mortality in developed countries. Women who have had a spontaneous preterm delivery are at much higherExpand
Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor.
TLDR
Although there were no complications attributable to the progestational drug, the study population was too small for assessment of immediate or long-term safety, however, the results indicate a possible obstetric use for this drug. Expand
The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
TLDR
It was concluded that pregnant military personnel were at increased risk for adverse pregnancy outcome, but that this risk was not altered by therapy with 17 alpha-hydroxyprogesterone caproate. Expand
...
1
2
3
4
5
...